Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 2, 2014Diagnostic PathologyOpen Access

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

ZZZhuqing ZhangFujian University of Traditional Chinese MedicineHMHua MengSoochow UniversityNWNan WangWeifang Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2014) studied this question.

synapsesocial.com/papers/6aad0909ed2359bb2ee04772https://doi.org/10.1186/1746-1596-9-135
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Micro RNA ‐143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer2013 · 74 citations
  2. 2Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study2012 · 229 citations
  3. 3Hepatogastroenterology2012 · 807 citations
  4. 4microRNA-200a is an independent prognostic factor of hepatocellular carcinoma and induces cell cycle arrest by targeting CDK62013 · 28 citations
  5. 5miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms2012 · 126 citations